Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 220 results found. Search for [ Drugs Controller General India ]

Results 1 to 21 of 220
BusinessToday.In
October 23, 2020
Dr Reddy's Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


Manoj Sharma
October 22, 2020
Dr Reddy's has partnered with Russian Direct Investment Fund to conduct trials of Sputnik V and distribute vaccine in India; after the cyber attack, its stock is 2.96% or Rs 149.20 down at Rs 4,897.55 compared to previous session's close of Rs 5,046.75


BusinessToday.In
October 16, 2020
India Stock Market Highlights Today: IndusInd Bank, Tata Steel, Infosys, ONGC, BPCL, Cipla, Kotak Bank, NTPC and Bharti Airtel were among prominent gainers. On the other hand, Asian Paints, Sun Pharma, Nestle, RIL, M&M, HCL Tech were among the top losers.


BusinessToday.In
October 15, 2020
Russian COVID-19 vaccine: Putin said on state TV that they have to increase production of first and second vaccines. \"We are continuing to cooperate with our foreign partners and will promote our vaccine abroad,\" he added


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


PTI
October 10, 2020
According to sources, the phase-2 trial of the Covaxin is going on and the second dose is yet to be given to volunteers at some sites


PTI
October 7, 2020
Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections


Reuters
October 6, 2020
The Hyderabad-based pharmaceutical company had applied to the Drugs Controller General of India (DCGI) late last week, seeking permission to conduct phase-3 human clinical trials of the Russian vaccine


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
September 26, 2020
Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country


BusinessToday.In
September 21, 2020
FELUDA tests approved by DCGI for commercial launch; will it live up to the consistency and efficacy of its namesake, Satyajit Ray's private investigator?


Rashi Bisaria
New Delhi, September 21, 2020
Farm bills passed in Rajya Sabha amid protests by opposition MPsThe Rajya Sabha has passed the Farmers' and Produce Trade and Commerce (Promotion and Facilitation) Bill, 2020 and Farmers (Empowerment and Protection) Agreement on Price Assurance and Farm Services Bill, 2020, through voice vote amid protest by opposition MPs and farmers' protests across Punjab and Haryana. The bills were passed in the Lok Sabha last week.Tata Consultancy Services sets up 11 COVID-19 isolation centres for staf...


BusinessToday.In
September 20, 2020
Tata CRISPR test meets high-quality benchmarks with 96 per cent sensitivity and 98 per cent specificity (accuracy) for detecting coronavirus; it shows result more quickly than traditional RT-PCR test kits and is less expensive


BusinessToday.In
September 19, 2020
The final clinical trial of coronavirus vaccine by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune from Monday


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


PAGES 1 OF 11  12345